Skip to main content
. 2020 Jun 24;20(3):2499–2505. doi: 10.3892/ol.2020.11768

Table II.

Association between ANGPTL4 expression and clinical parameters in 205 patients with invasive ductal carcinoma.

ANGPTL4 expression, n

Variable Negative Weakly positive Moderately positive Strongly positive P-value
Age, years 0.371
  <55 38 28 30 12
  ≥55 37 25 22 13
Tumor size, cm <0.001
  ≤2.0 46 10 15 7
  2.1–5.0 29 41 30 8
  >5.0 0 2 7 10
pTNM <0.001
  I 30 6 4 0
  II 29 38 28 7
  III 16 7 14 12
  IV 0 2 6 6
Grade <0.001
  I 25 8 4 0
  II 34 31 31 15
  III 16 14 17 10
ER 0.955
  – 38 29 28 12
  + 37 24 24 13
PR 0.793
  – 41 30 22 18
  + 34 23 30 7
HER2 0.211
  – 35 32 22 9
  1+ 16 5 18 8
  2+ 14 4 6 4
  3+ 10 12 6 4
Lymph node metastasis <0.001
  – 51 29 25 6
  + 24 24 27 19
Distant metastasis <0.001
  – 68 46 37 15
  + 7 7 15 10
Local recurrence
  – 75 51 48 19 <0.001
  + 0 2 4 6

ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2; ANGPTL4, angiopoietin-like 4.